Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharmacol ; 357(2-3): 163-9, 1998 Sep 18.
Article in English | MEDLINE | ID: mdl-9797032

ABSTRACT

A behavioral study was performed in an attempt to understand the neuronal mechanisms involved in the thyrotropin-releasing hormone (TRH)-induced improvement of consciousness after concussive head injury in the mouse. Intravenous administration of TRH dose dependently shortened the duration of unconsciousness after concussion in the mouse (ED50 = 3.2 mg/kg). The improvement of recovery evoked by TRH (3 mg/kg i.v.) after concussion was not affected by i.p. pretreatment with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine, alpha-methyl-para-tyrosine, p-chlorophenylalanine, scopolamine or methylscopolamine. However, mecamylamine or hexamethonium i.p. pretreatment completely inhibited the TRH-induced improvement of outcome in traumatic brain injury. The results imply that TRH-induced improvement of recovery after concussion is not associated with increased activity of monoaminergic neurons in the brain. These results suggest that the inhibitory effect of TRH upon unconsciousness after concussion in mice is mainly produced by activation of central cholinergic systems via nicotinic receptors whereas muscarinic receptors seem to be not implicated.


Subject(s)
Brain Concussion/drug therapy , Consciousness/drug effects , Parasympathetic Nervous System/physiology , Receptors, Muscarinic/physiology , Receptors, Nicotinic/physiology , Thyrotropin-Releasing Hormone/pharmacology , Animals , Biogenic Monoamines/metabolism , Cholinergic Antagonists/pharmacology , Male , Mice , Muscarinic Antagonists/pharmacology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...